• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

61742 例确诊 COVID-19 感染患者的临床特征、实验室检查结果、影像学表现和结局:系统评价和荟萃分析。

Clinical characteristics, laboratory findings, radiographic signs and outcomes of 61,742 patients with confirmed COVID-19 infection: A systematic review and meta-analysis.

机构信息

Department of Biological Sciences, University of Calgary, Calgary, AB, Canada.

Department of Virology, Faculty of Medicine, Iran University of Medical Science, Tehran, Iran.

出版信息

Microb Pathog. 2020 Oct;147:104390. doi: 10.1016/j.micpath.2020.104390. Epub 2020 Jul 15.

DOI:10.1016/j.micpath.2020.104390
PMID:32681968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7361116/
Abstract

INTRODUCTION

In the current time where we face a COVID-19 pandemic, there is no vaccine or effective treatment at this time. Therefore, the prevention of COVID-19 and the rapid diagnosis of infected patients is crucial.

METHOD

We searched all relevant literature published up to February 28, 2020. We used Random-effect models to analyze the appropriateness of the pooled results.

RESULT

Eighty studies were included in the meta-analysis, including 61,742 patients with confirmed COVID-19 infection. 62.5% (95% CI 54.5-79, p < 0.001) of patients had a history of recent travel endemic area or contact with them. The most common symptoms among COVID-19 infected patients were fever 87% (95% CI 73-93, p < 0.001), and cough 68% (95% CI 55.5-74, p < 0.001)), respectively. The laboratory analysis showed that thrombocytosis was present in 61% (95% CI 41-78, p < 0.001) CRP was elevated in 79% (95% CI 65-91, p < 0.001), and lymphopenia in 57.5% (95% CI 42-79, p < 0.001). The most common radiographic signs were bilateral involvement in 81% (95% CI 62.5-87, p < 0.001), consolidation in 73.5% (95% CI 50.5-91, p < 0.001), and ground-glass opacity 73.5% (95% CI 40-90, p < 0.001) of patients. Case fatality rate (CFR) in <15 years old was 0.6%, in >50 years old was 39.5%, and in all range group was 6%.

CONCLUSIONS

Fever and cough are the most common symptoms of COVID-19 infection in the literature published to date. Thombocytosis, lymphopenia, and increased CRP were common lab findings although most patients included in the overall analysis did not have laboratory values reported. Among Chinese patients with COVID-19, rates of hospitalization, critical condition, and hospitalization were high in this study, but these findings may be biased by reporting only confirmed cases.

摘要

简介

在当前我们面临 COVID-19 大流行的时代,目前尚无疫苗或有效治疗方法。因此,预防 COVID-19 和快速诊断感染患者至关重要。

方法

我们搜索了截至 2020 年 2 月 28 日发表的所有相关文献。我们使用随机效应模型分析汇总结果的适宜性。

结果

共有 80 项研究纳入荟萃分析,包括 61742 例确诊 COVID-19 感染患者。62.5%(95%置信区间 54.5-79,p<0.001)的患者有近期前往流行地区旅行或接触的病史。COVID-19 感染患者最常见的症状是发热 87%(95%置信区间 73-93,p<0.001),咳嗽 68%(95%置信区间 55.5-74,p<0.001)。实验室分析显示血小板增多症占 61%(95%置信区间 41-78,p<0.001),CRP 升高占 79%(95%置信区间 65-91,p<0.001),淋巴细胞减少占 57.5%(95%置信区间 42-79,p<0.001)。最常见的影像学征象是双侧受累占 81%(95%置信区间 62.5-87,p<0.001),实变占 73.5%(95%置信区间 50.5-91,p<0.001),磨玻璃影占 73.5%(95%置信区间 40-90,p<0.001)。年龄<15 岁的病死率(CFR)为 0.6%,年龄>50 岁的病死率为 39.5%,所有年龄段的病死率为 6%。

结论

发热和咳嗽是迄今为止发表的文献中 COVID-19 感染的最常见症状。虽然大多数患者的实验室值没有报告,但血小板增多症、淋巴细胞减少症和 CRP 升高是常见的实验室发现。在本研究中,中国 COVID-19 患者的住院率、重症率和住院率均较高,但这些发现可能因仅报告确诊病例而存在偏差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e707/7361116/100761ed84a2/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e707/7361116/b9ff24ea8b6e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e707/7361116/11659861fe41/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e707/7361116/100761ed84a2/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e707/7361116/b9ff24ea8b6e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e707/7361116/11659861fe41/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e707/7361116/100761ed84a2/gr3_lrg.jpg

相似文献

1
Clinical characteristics, laboratory findings, radiographic signs and outcomes of 61,742 patients with confirmed COVID-19 infection: A systematic review and meta-analysis.61742 例确诊 COVID-19 感染患者的临床特征、实验室检查结果、影像学表现和结局:系统评价和荟萃分析。
Microb Pathog. 2020 Oct;147:104390. doi: 10.1016/j.micpath.2020.104390. Epub 2020 Jul 15.
2
Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis.比较确诊的 COVID-19 与 SARS 和 MERS 病例的临床特征、实验室检查结果、影像学表现和结局:一项系统评价和荟萃分析。
Rev Med Virol. 2020 Jul;30(4):e2112. doi: 10.1002/rmv.2112. Epub 2020 Jun 5.
3
Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis.住院的 SARS-CoV-2 感染患者的临床特征:一项单臂荟萃分析。
J Med Virol. 2020 Jun;92(6):612-617. doi: 10.1002/jmv.25735. Epub 2020 Mar 11.
4
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis.新型冠状病毒肺炎的临床、实验室和影像学特征:系统评价和荟萃分析。
Travel Med Infect Dis. 2020 Mar-Apr;34:101623. doi: 10.1016/j.tmaid.2020.101623. Epub 2020 Mar 13.
5
What we know so far about Coronavirus Disease 2019 in children: A meta-analysis of 551 laboratory-confirmed cases.目前我们对2019年儿童冠状病毒病的了解:对551例实验室确诊病例的荟萃分析。
Pediatr Pulmonol. 2020 Aug;55(8):2115-2127. doi: 10.1002/ppul.24869. Epub 2020 Jun 10.
6
Epidemiologic, clinical, and laboratory findings of the COVID-19 in the current pandemic: systematic review and meta-analysis.新型冠状病毒肺炎大流行期间的流行病学、临床和实验室研究结果:系统评价和荟萃分析。
BMC Infect Dis. 2020 Aug 31;20(1):640. doi: 10.1186/s12879-020-05371-2.
7
How should our testing behaviour change with time in children in current COVID-19 pandemic?在当前 COVID-19 大流行期间,儿童的检测行为应如何随时间变化?
Eur J Clin Invest. 2020 Oct;50(10):e13351. doi: 10.1111/eci.13351. Epub 2020 Aug 4.
8
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
9
COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.COVID-19 患者的临床特征、出院率和死亡率的荟萃分析。
J Med Virol. 2020 Jun;92(6):577-583. doi: 10.1002/jmv.25757. Epub 2020 Mar 23.
10
Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis.与 COVID-19 死亡相关的临床特征、实验室结局特征、合并症和并发症:系统评价和荟萃分析。
Aging Clin Exp Res. 2020 Sep;32(9):1869-1878. doi: 10.1007/s40520-020-01664-3. Epub 2020 Jul 30.

引用本文的文献

1
Hematological Markers in Thromboembolic Events: A Comparative Study of COVID-19 and Non-COVID-19 Hospitalized Patients.血栓栓塞事件中的血液学标志物:COVID-19与非COVID-19住院患者的比较研究
J Clin Med. 2025 May 5;14(9):3192. doi: 10.3390/jcm14093192.
2
An electronic patient-reported outcome symptom monitor: the Chinese experience with rapid development of a ready-to-go symptom monitor.电子患者报告结局症状监测器:中国快速开发即用型症状监测器的经验。
BMC Public Health. 2024 Oct 29;24(1):2989. doi: 10.1186/s12889-024-20518-5.
3
Human transferrin receptor can mediate SARS-CoV-2 infection.

本文引用的文献

1
HRCT imaging features in representative imported cases of 2019 novel coronavirus pneumonia.2019新型冠状病毒肺炎典型输入性病例的高分辨率CT成像特征
Precis Clin Med. 2020 Mar;3(1):9-13. doi: 10.1093/pcmedi/pbaa004. Epub 2020 Feb 11.
2
Imaging Profile of the COVID-19 Infection: Radiologic Findings and Literature Review.新型冠状病毒肺炎感染的影像学表现:放射学发现与文献综述
Radiol Cardiothorac Imaging. 2020 Feb 13;2(1):e200034. doi: 10.1148/ryct.2020200034. eCollection 2020 Feb.
3
Clinical characteristics of a group of deaths with COVID-19 pneumonia in Wuhan, China: a retrospective case series.
人转铁蛋白受体可以介导 SARS-CoV-2 感染。
Proc Natl Acad Sci U S A. 2024 Mar 5;121(10):e2317026121. doi: 10.1073/pnas.2317026121. Epub 2024 Feb 26.
4
Prevalence of Influenza Viruses A and B, Adenovirus, Respiratory Syncytial Virus, and Human Metapneumonia Viruses among Children with Acute Respiratory Tract Infection.急性呼吸道感染儿童中甲型和乙型流感病毒、腺病毒、呼吸道合胞病毒及人偏肺病毒的流行情况
Adv Virol. 2024 Jan 22;2024:7613948. doi: 10.1155/2024/7613948. eCollection 2024.
5
[Early prediction of severe COVID-19 in patients with Sjögren's syndrome].[干燥综合征患者中重症新型冠状病毒肺炎的早期预测]
Beijing Da Xue Xue Bao Yi Xue Ban. 2023 Dec 18;55(6):1007-1012. doi: 10.19723/j.issn.1671-167X.2023.06.008.
6
Smoking and prevalence of COVID-19: Evidence from studies from January 2020 - May 2020.吸烟与2019冠状病毒病的流行情况:来自2020年1月至2020年5月研究的证据。
AIMS Public Health. 2023 Jun 19;10(3):538-552. doi: 10.3934/publichealth.2023038. eCollection 2023.
7
Outcomes of COVID-19 in immunocompromised patients: a single center experience.免疫功能低下患者的新型冠状病毒肺炎结局:单中心经验
Virusdisease. 2023 Sep;34(3):373-382. doi: 10.1007/s13337-023-00832-z. Epub 2023 Aug 10.
8
The main protease of SARS-CoV-2 cleaves histone deacetylases and DCP1A, attenuating the immune defense of the interferon-stimulated genes.SARS-CoV-2 的主要蛋白酶可切割组蛋白去乙酰化酶和 DCP1A,从而削弱干扰素刺激基因的免疫防御。
J Biol Chem. 2023 Mar;299(3):102990. doi: 10.1016/j.jbc.2023.102990. Epub 2023 Feb 8.
9
Clinical and demographic characteristics of COVID-19 cases in Brunei Darussalam: comparison between the first and second waves, 2020 and 2021.文莱达鲁萨兰国 2020 年和 2021 年第一波和第二波 COVID-19 病例的临床和人口统计学特征比较。
Western Pac Surveill Response J. 2022 Aug 25;13(3):1-7. doi: 10.5365/wpsar.2022.13.3.925. eCollection 2022 Jul-Sep.
10
Primary adrenal insufficiency and myocarditis in COVID-19 disease: a case report.新型冠状病毒疾病中的原发性肾上腺功能不全和心肌炎:一例报告。
BMC Endocr Disord. 2022 Dec 31;22(1):336. doi: 10.1186/s12902-022-01257-3.
中国武汉一组 COVID-19 肺炎死亡病例的临床特征:回顾性病例系列研究。
BMC Infect Dis. 2020 Sep 22;20(1):695. doi: 10.1186/s12879-020-05423-7.
4
In-flight transmission cluster of COVID-19: a retrospective case series.航班中 COVID-19 的传播聚集:一项回顾性病例系列研究。
Infect Dis (Lond). 2020 Nov-Dec;52(12):891-901. doi: 10.1080/23744235.2020.1800814. Epub 2020 Jul 31.
5
Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2.新型冠状病毒(SARS-CoV-2)受体ACE2的单细胞RNA表达谱分析
Am J Respir Crit Care Med. 2020 Sep 1;202(5):756-759. doi: 10.1164/rccm.202001-0179LE.
6
Clinical characteristics of 82 cases of death from COVID-19.COVID-19 死亡 82 例的临床特征。
PLoS One. 2020 Jul 9;15(7):e0235458. doi: 10.1371/journal.pone.0235458. eCollection 2020.
7
Clinical outcomes of 402 patients with COVID-2019 from a single center in Wuhan, China.中国武汉某单一中心 402 例 COVID-19 患者的临床结局。
J Med Virol. 2020 Nov;92(11):2751-2757. doi: 10.1002/jmv.26168. Epub 2020 Jun 29.
8
Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis.比较确诊的 COVID-19 与 SARS 和 MERS 病例的临床特征、实验室检查结果、影像学表现和结局:一项系统评价和荟萃分析。
Rev Med Virol. 2020 Jul;30(4):e2112. doi: 10.1002/rmv.2112. Epub 2020 Jun 5.
9
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.羟氯喹和阿奇霉素联合治疗 COVID-19 患者:法国马赛 1061 例回顾性分析。
Travel Med Infect Dis. 2020 May-Jun;35:101738. doi: 10.1016/j.tmaid.2020.101738. Epub 2020 May 5.
10
Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study.中国深圳 391 例病例及其 1286 名密切接触者的 COVID-19 流行病学和传播:一项回顾性队列研究。
Lancet Infect Dis. 2020 Aug;20(8):911-919. doi: 10.1016/S1473-3099(20)30287-5. Epub 2020 Apr 27.